MedTrace Logo

EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment

NCT07555171 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-05-07

No results posted yet for this study

Summary

This study plans to learn if certain markers found during electroencephalogram (EEG) analysis could predict fenfluramine responsiveness to give clinicians greater insight into the effectiveness of fenfluramine in people with Lennox Gastaut Syndrome (LGS).

Conditions

  • Lennox Gastaut Syndrome (LGS)

Interventions

DRUG

fenfluramine HCl

Patients who receive fenfluramine will be enrolled in this non-interventional study.

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY

  • University of Chicago

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-12-31
Completion
2028-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07555171 on ClinicalTrials.gov